DK1104297T3 - Sammensætninger til behandling af kronisk lymfocytisk leukæmi - Google Patents
Sammensætninger til behandling af kronisk lymfocytisk leukæmiInfo
- Publication number
- DK1104297T3 DK1104297T3 DK99937222T DK99937222T DK1104297T3 DK 1104297 T3 DK1104297 T3 DK 1104297T3 DK 99937222 T DK99937222 T DK 99937222T DK 99937222 T DK99937222 T DK 99937222T DK 1104297 T3 DK1104297 T3 DK 1104297T3
- Authority
- DK
- Denmark
- Prior art keywords
- lymphocytic leukemia
- chronic lymphocytic
- compositions
- treatment
- compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9246698P | 1998-07-09 | 1998-07-09 | |
US9487898P | 1998-07-29 | 1998-07-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1104297T3 true DK1104297T3 (da) | 2006-05-29 |
Family
ID=26785713
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK99937222T DK1104297T3 (da) | 1998-07-09 | 1999-07-08 | Sammensætninger til behandling af kronisk lymfocytisk leukæmi |
Country Status (12)
Country | Link |
---|---|
US (3) | US6573292B1 (fr) |
EP (1) | EP1104297B8 (fr) |
JP (1) | JP2002520282A (fr) |
AT (1) | ATE315392T1 (fr) |
AU (1) | AU767586B2 (fr) |
CA (1) | CA2336932A1 (fr) |
DE (1) | DE69929440T2 (fr) |
DK (1) | DK1104297T3 (fr) |
ES (1) | ES2255287T3 (fr) |
NZ (1) | NZ509376A (fr) |
PT (1) | PT1104297E (fr) |
WO (1) | WO2000002555A1 (fr) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2336932A1 (fr) * | 1998-07-09 | 2000-01-20 | Francis A. Nardella | Procedes et compositions pour le traitement de la leucemie lymphocitaire chronique |
US7105560B1 (en) | 1999-07-23 | 2006-09-12 | The Regents Of The University Of California | Use of etodolac in the treatment of multiple myeloma |
US7129262B2 (en) | 1999-07-23 | 2006-10-31 | The Regents Of The University Of California | Indole compounds useful for the treatment of cancer |
US7361680B2 (en) | 1999-07-23 | 2008-04-22 | The Regents Of The University Of California | Indole compounds useful for the treatment of cancer |
US6545034B1 (en) | 1999-07-23 | 2003-04-08 | The Regents Of The University Of California | Use of etodolac for the treatment of chronic lymphocytic leukemia |
US7151100B1 (en) | 1999-07-23 | 2006-12-19 | The Regents Of The University Of California | Indole compounds useful for the treatment of cancer |
US7211599B2 (en) | 2002-09-19 | 2007-05-01 | The Regents Of The University Of California | Use of etodolac to treat hyperplasia |
WO2005033113A2 (fr) * | 2003-10-02 | 2005-04-14 | Cephalon, Inc | Derives indoles |
US7638331B2 (en) | 2004-01-02 | 2009-12-29 | The Administration of the Tulane Rducation Fund | Directed apoptosis in COX-2 overexpressing cancer cells through expression targeted gene delivery |
AU2005317047A1 (en) * | 2004-11-05 | 2006-06-22 | Cephalon, Inc. | Cancer treatments |
US8436190B2 (en) | 2005-01-14 | 2013-05-07 | Cephalon, Inc. | Bendamustine pharmaceutical compositions |
AR072777A1 (es) | 2008-03-26 | 2010-09-22 | Cephalon Inc | Formas solidas de clorhidrato de bendamustina |
RU2474612C2 (ru) * | 2008-05-20 | 2013-02-10 | Инкурон ЛЛК | Индуцирование гибели клеток путем ингибирования адаптивного теплового шокового ответа |
CN102164579B (zh) * | 2008-09-25 | 2014-10-15 | 赛福伦公司 | 苯达莫司汀的液体配制品 |
US8076366B2 (en) * | 2009-01-15 | 2011-12-13 | Cephalon, Inc. | Forms of bendamustine free base |
JP2013537552A (ja) | 2010-08-18 | 2013-10-03 | デル マー ファーマスーティカルズ | ジアンヒドロガラクチトール及びジアセチルジアンヒドロガラクチトール等の置換ヘキシトールを含む準最適に投与された化合物の治療的有効性を改良するための組成物及び方法 |
AU2012389562A1 (en) | 2011-08-17 | 2014-07-24 | Dennis Brown | Compositions and methods to improve the therapeutic benefit of subotimally administered chemical compounds including substituted hexitols such as dibromodulcitol |
AU2013209394A1 (en) | 2012-01-20 | 2014-08-28 | Dennis Brown | Use of substituted hexitols including dianhydrogalactitol and analogs to treat neoplastic disease and cancer stem cells including glioblastoma multforme and medulloblastoma |
WO2013142817A2 (fr) | 2012-03-23 | 2013-09-26 | Dennis Brown | Compositions et procédés d'amélioration du bénéfice thérapeutique de l'indirubine et de ses analogues y compris du mésoindigo |
WO2013169600A1 (fr) | 2012-05-09 | 2013-11-14 | Delmar Pharmaceuticals | Utilisation vétérinaire du dianhydrogalactitol, du diacétyldianhydrogalactitol, et du dibromodulcitol pour traiter des malignités |
EP2872161B1 (fr) | 2012-06-26 | 2020-12-16 | Del Mar Pharmaceuticals | Dianhydrogalactitol pour utilisation dans le traitement de malignités résistantes à un inhibiteur de tyrosine kinase chez des patients ayant des polymorphismes génétiques ou des dérégulations ou des mutations d'ahi1 |
KR102359214B1 (ko) | 2014-04-04 | 2022-02-07 | 델 마 파마슈티컬스 | 폐의 비소세포 암종 및 난소암을 치료하기 위한 디안하이드로갈락티톨 및 이의 유사체 또는 유도체 |
US10434086B2 (en) | 2014-04-06 | 2019-10-08 | Incuron, Inc. | Combination therapies with curaxins |
Family Cites Families (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1071897B (fr) | 1957-12-19 | 1959-12-24 | ||
US3843480A (en) | 1963-08-28 | 1974-10-22 | D Dreher | Dry dry transfer |
US3948262A (en) | 1969-04-01 | 1976-04-06 | Alza Corporation | Novel drug delivery device |
US3993073A (en) | 1969-04-01 | 1976-11-23 | Alza Corporation | Novel drug delivery device |
US3710795A (en) | 1970-09-29 | 1973-01-16 | Alza Corp | Drug-delivery device with stretched, rate-controlling membrane |
US3974179A (en) | 1971-06-01 | 1976-08-10 | American Home Products Corporation | 1,3,4,9-Tetrahydropyrano[3,4-b]indole-1-acetamides and derivatives |
US3939178A (en) | 1971-06-01 | 1976-02-17 | American Home Products Corporation | Certain pyrano [3,4-b]indoles and thiopyrano[3,4-b]indoles |
US3843681A (en) | 1971-06-01 | 1974-10-22 | American Home Prod | 1-carboxamido pyrano(thiopyrano)(3,4-6)indole derivatives |
US3948254A (en) | 1971-11-08 | 1976-04-06 | Alza Corporation | Novel drug delivery device |
US3839178A (en) * | 1972-10-05 | 1974-10-01 | Gen Electric | Potentiometric oxygen sensor |
US4310509A (en) | 1979-07-31 | 1982-01-12 | Minnesota Mining And Manufacturing Company | Pressure-sensitive adhesive having a broad spectrum antimicrobial therein |
US4291015A (en) | 1979-08-14 | 1981-09-22 | Key Pharmaceuticals, Inc. | Polymeric diffusion matrix containing a vasodilator |
JPS5777617A (en) | 1980-10-20 | 1982-05-15 | Nichiban Co Ltd | Plaster for cardiac disease |
IL61721A (en) | 1980-12-16 | 1984-03-30 | Blank Izhak | Nitroglycerin preparations |
US4542013A (en) | 1981-07-08 | 1985-09-17 | Key Pharmaceuticals, Inc. | Trinitroglycerol sustained release vehicles and preparation therefrom |
US4460562A (en) | 1982-01-06 | 1984-07-17 | Key Pharmaceuticals, Inc. | Polymeric diffusion matrix containing propranolol |
US4485097A (en) | 1982-05-26 | 1984-11-27 | Massachusetts Institute Of Technology | Bone-equivalent and method for preparation thereof |
US4542012A (en) | 1982-07-02 | 1985-09-17 | Minnesota Mining And Manufacturing Company | Film-forming composition containing an antimicrobial agent and methods |
US4608249A (en) | 1982-11-02 | 1986-08-26 | Nitto Electric Industrial Co., Ltd. | Hydrophilic therapeutic material |
IT1153909B (it) | 1982-12-17 | 1987-01-21 | Sogimi Srl | Polimeri reattivi per la cura di affezioni cutanee |
GB8317576D0 (en) | 1983-06-29 | 1983-08-03 | Shaw A S W | Consumer tobacco products |
US4597961A (en) | 1985-01-23 | 1986-07-01 | Etscorn Frank T | Transcutaneous application of nicotine |
US4585877A (en) | 1985-05-06 | 1986-04-29 | American Home Products Corporation | Process for preparing 1,8-diethyl-1,3,4,9-tetrahydropyrano(3,4-b)-indole-1-acetic acid, etodolac |
GB8514665D0 (en) | 1985-06-11 | 1985-07-10 | Eroceltique Sa | Oral pharmaceutical composition |
US4686213A (en) | 1986-08-15 | 1987-08-11 | American Home Products Corporation | Substituted 1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acids |
US4748252A (en) | 1986-08-15 | 1988-05-31 | American Home Products Corporation | Substituted 1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic acids |
CA2131992A1 (fr) | 1992-03-13 | 1993-09-16 | James W. Young | Methodes et compositions a base d'antipyretique et d'analgesique, renfermant du r-etodolac optiquement pur |
US5955504A (en) | 1995-03-13 | 1999-09-21 | Loma Linda University Medical Center | Colorectal chemoprotective composition and method of preventing colorectal cancer |
US5981592A (en) * | 1995-03-13 | 1999-11-09 | Loma Linda University Medical Center | Method and composition for treating cystic fibrosis |
US6160018A (en) | 1995-03-13 | 2000-12-12 | Loma Linda University Medical Center | Prophylactic composition and method for alzheimer's Disease |
US5599946A (en) | 1995-05-30 | 1997-02-04 | Teva Pharmaceutical Industries Ltd. | 3-(2-trialkylsilyloxy)ethyl-7-ethyl-1H-indoles and method for their preparation |
US5968974A (en) | 1995-07-19 | 1999-10-19 | Merck & Co., Inc. | Method of treating colonic adenomas |
DE69632632T2 (de) * | 1995-07-19 | 2005-05-25 | Merck & Co., Inc. | Behandlungsverfahren für darmadenome |
WO1997048391A2 (fr) | 1996-06-21 | 1997-12-24 | Advanced Research And Technology Institute | Methodes et compositions a base de r-ibuprofene |
CA2261588A1 (fr) * | 1996-07-26 | 1998-02-05 | American Home Products Corporation | Inhibiteurs pyranoindole et carbazol de cox-2 |
US5776967A (en) | 1996-07-26 | 1998-07-07 | American Home Products Corporation | Pyranoindole inhibitors of COX--2 |
ATE493983T1 (de) * | 1996-11-05 | 2011-01-15 | Childrens Medical Center | Thalidomide und dexamethason für die behandlung von tumors |
US5939455A (en) * | 1997-03-11 | 1999-08-17 | Beacon Laboratories, Inc. | Therapeutic augmentation of oxyalkylene diesters and butyric acid derivatives |
CA2336932A1 (fr) * | 1998-07-09 | 2000-01-20 | Francis A. Nardella | Procedes et compositions pour le traitement de la leucemie lymphocitaire chronique |
US7105560B1 (en) | 1999-07-23 | 2006-09-12 | The Regents Of The University Of California | Use of etodolac in the treatment of multiple myeloma |
US6545034B1 (en) * | 1999-07-23 | 2003-04-08 | The Regents Of The University Of California | Use of etodolac for the treatment of chronic lymphocytic leukemia |
WO2002012188A2 (fr) | 2000-08-09 | 2002-02-14 | The Regents Of The University Of California | Composes indoliques utilises dans le traitement du cancer |
-
1999
- 1999-07-08 CA CA002336932A patent/CA2336932A1/fr not_active Abandoned
- 1999-07-08 NZ NZ509376A patent/NZ509376A/en unknown
- 1999-07-08 AU AU52098/99A patent/AU767586B2/en not_active Ceased
- 1999-07-08 ES ES99937222T patent/ES2255287T3/es not_active Expired - Lifetime
- 1999-07-08 DK DK99937222T patent/DK1104297T3/da active
- 1999-07-08 US US09/720,992 patent/US6573292B1/en not_active Expired - Fee Related
- 1999-07-08 WO PCT/US1999/015501 patent/WO2000002555A1/fr active IP Right Grant
- 1999-07-08 DE DE69929440T patent/DE69929440T2/de not_active Expired - Fee Related
- 1999-07-08 AT AT99937222T patent/ATE315392T1/de not_active IP Right Cessation
- 1999-07-08 EP EP99937222A patent/EP1104297B8/fr not_active Expired - Lifetime
- 1999-07-08 JP JP2000558815A patent/JP2002520282A/ja active Pending
- 1999-07-08 PT PT99937222T patent/PT1104297E/pt unknown
-
2003
- 2003-03-31 US US10/404,943 patent/US6921772B2/en not_active Expired - Fee Related
-
2005
- 2005-07-26 US US11/190,356 patent/US20050261356A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
ES2255287T3 (es) | 2006-06-16 |
AU767586B2 (en) | 2003-11-20 |
AU5209899A (en) | 2000-02-01 |
EP1104297A1 (fr) | 2001-06-06 |
US20050261356A1 (en) | 2005-11-24 |
ATE315392T1 (de) | 2006-02-15 |
NZ509376A (en) | 2003-10-31 |
CA2336932A1 (fr) | 2000-01-20 |
EP1104297A4 (fr) | 2003-01-02 |
WO2000002555A1 (fr) | 2000-01-20 |
US20030232874A1 (en) | 2003-12-18 |
US6573292B1 (en) | 2003-06-03 |
DE69929440D1 (de) | 2006-04-06 |
US6921772B2 (en) | 2005-07-26 |
PT1104297E (pt) | 2006-05-31 |
EP1104297B8 (fr) | 2006-05-03 |
JP2002520282A (ja) | 2002-07-09 |
EP1104297B1 (fr) | 2006-01-11 |
DE69929440T2 (de) | 2006-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1104297T3 (da) | Sammensætninger til behandling af kronisk lymfocytisk leukæmi | |
ATE361069T1 (de) | Phytochemikalien zur behandlung von mastalgie und endometriose | |
TR200003206T2 (tr) | İndol türevleri ve patolojik hücre çoğalmasının neden olduğu habis hastalıklar ve diğer hastalıkların tedavisinde kullanımları. | |
EA199900373A2 (ru) | Фармацевтические композиции | |
TR199802269T2 (xx) | Endotelin resept�r antagonistleri olarak faydal� indol t�revleri. | |
NZ506329A (en) | Inhibitors of phospholipase enzymes | |
BR0215360A (pt) | Derivados de indolina úteis como inibidores de proteìna quinase | |
ECSP045104A (es) | Ligandos de los receptores de los cannabinoides | |
DK0840732T3 (da) | Substituerede benzolactamforbindelser som substans P-antagonister | |
DE60305484D1 (de) | Verbindungen und deren verwendung als 5-ht inhibitore | |
TR199800585T2 (xx) | COX-2 �nhibit�rleri Olarak (Metils�lfonil)Fenil-2-(5H)-Furanonlar. | |
FI960399A0 (fi) | Perhydroisoindolijohdannaisia P-aineen antagonisteina | |
IS2750B (is) | Leiðarafesting | |
MY136767A (en) | Formulations comprising an indolinone compound | |
TR200001906T2 (tr) | Koks-Inhibitörleri olarak 2,3-ikameli indol bileşikleri. | |
NZ507835A (en) | Heterocyclic derivatives which inhibit factor XA | |
NO20060510L (no) | Emulgerende systemer inneholdende azetidinderivater | |
AU3548900A (en) | Medicament for inhibiting NF-kappaB | |
DK0971922T3 (da) | Tetrahydropyrido-forbindelser | |
TR200001452T2 (tr) | Bifenilamidin türevleri. | |
DK1406902T3 (da) | Hexahydroazepino[4,5-g]indoler og -indoliner som 5-HT-receptor-ligander | |
AR025068A1 (es) | Pirazinas sustituidas y piridazinas fusionadas, composicion farmaceutica que las comprenden, uso de dichos compuestos para la manufactura de un medicamentocon actividad inhibidora de angiogenesis | |
ATE266029T1 (de) | Substituierte pyrrolobenzimidazolderivate zur entzündungshemmung | |
AP2001002149A0 (en) | Indole derivatives(Priority title) | |
EP1671631A3 (fr) | Compositions pour le traitement de léucemie lymphoïde chronique |